의료보험재정보호를 위한 약제비 억제방안에 관한 연구

Abstract

The drug cost is more difficult to control than any other medical care cost and, moreover, it is not so easy to stabilize the insurance finance by controlling it, The drug cost increase related to the medical insurance can be contained, in the long run, by the separation of dispensary from medical practice and, in the short run, by the strict selection of drugs covered under the medical insurance and the improvement of management as well as disclosure of drug prices. For the former, the revision of medical law, the establishment of medical care delivery system, the presence of pharmacy in rural areas, the change in attitude toward drugs related to medical insurance, and the public education are necessary. For the latter, the reduction of existing price differences among medicaments of the identical component and content, the restriction of the use of the OTC medicaments and mixed compound, and the promotion of hospital-prepared medicaments which are cheaper than those supplied by pharmaceutical companies are necessary.